Sarepta Therapeutics
SRPT
SRPT
481 hedge funds and large institutions have $14B invested in Sarepta Therapeutics in 2024 Q2 according to their latest regulatory filings, with 120 funds opening new positions, 178 increasing their positions, 128 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
17% more funds holding
Funds holding: 411 → 481 (+70)
7% more funds holding in top 10
Funds holding in top 10: 15 → 16 (+1)
5.25% more ownership
Funds ownership: 88.68% → 93.93% (+5.2%)
Holders
481
Holding in Top 10
16
Calls
$650M
Puts
$325M
Top Buyers
| 1 | +$690M | |
| 2 | +$319M | |
| 3 | +$274M | |
| 4 |
Jane Street
New York
|
+$93.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$80.9M |
Top Sellers
| 1 | -$212M | |
| 2 | -$187M | |
| 3 | -$170M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$118M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$81M |